Geode Capital Management
CADL icon

Geode Capital Management’s Candel Therapeutics CADL Stock Holding History

Geode Capital Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
1,571,021
+535,586
+52% +$4.05M ﹤0.01% 2276
2026
Q1 		$5.07M Buy
1,035,435
+57,923
+6% +$315K ﹤0.01% 2732
2025
Q4 		$5.52M Buy
977,512
+49,315
+5% +$265K ﹤0.01% 2713
2025
Q3 		$4.73M Buy
928,197
+24,227
+3% +$140K ﹤0.01% 2811
2025
Q2 		$4.57M Buy
903,970
+216,509
+31% +$1.11M ﹤0.01% 2771
2025
Q1 		$3.89M Buy
687,461
+232,037
+51% +$1.9M ﹤0.01% 2767
2024
Q4 		$3.95M Buy
455,424
+6,427
+1% +$38K ﹤0.01% 2855
2024
Q3 		$3.11M Buy
448,997
+51,111
+13% +$318K ﹤0.01% 2970
2024
Q2 		$2.47M Buy
397,886
+252,180
+173% +$1.89M ﹤0.01% 3063
2024
Q1 		$230K Buy
145,706
+6,453
+5% +$9.58K ﹤0.01% 3895
2023
Q4 		$205K Hold
139,253
– – ﹤0.01% 3934
2023
Q3 		$130K Buy
139,253
+8,050
+6% +$9.3K ﹤0.01% 4158
2023
Q2 		$165K Hold
131,203
– – ﹤0.01% 4125
2023
Q1 		$180K Hold
131,203
– – ﹤0.01% 4103
2022
Q4 		$234K Buy
131,203
+2,357
+2% +$4.67K ﹤0.01% 4010
2022
Q3 		$404K Buy
128,846
+53,629
+71% +$182K ﹤0.01% 3838
2022
Q2 		$243K Hold
75,217
– – ﹤0.01% 4145
2022
Q1 		$382K Buy
75,217
+16,932
+29% +$84.1K ﹤0.01% 4075
2021
Q4 		$455K Buy
58,285
+37,890
+186% +$368K ﹤0.01% 4106
2021
Q3 		$221K Buy
+20,395
New +$169K ﹤0.01% 4410

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $617M AUM 69.99% 1-Year Est. Return

Geode Capital Management's CADL Position: Q2 2026 in Review

Geode Capital Management increased its Candel Therapeutics (CADL) stake by 52% in Q2 2026, buying an estimated $4.05M and bringing the position to 1,571,021 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Geode Capital Management first reported a position in CADL in Q3 2021 and has held it in 20 quarters since. 137 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Geode Capital Management held 1,571,021 shares of Candel Therapeutics worth $16.2M as of Q2 2026.
  • Geode Capital Management bought 535,586 Candel Therapeutics shares in Q2 2026, an estimated $4.05M.
  • Candel Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2276 holding.
  • Geode Capital Management first reported a position in Candel Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 137 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.